Pancreatic Cancer Research

ResearcherQueen Mary University of LondonNo recent work listed

Kirtiman Srivastava

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-3612-747X; OpenAlex author ID A5060498938. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 2 papers

Papers 2

  1. Urine biomarkers enable pancreatic cancer detection up to 2 years before diagnosis. Co-author DOI 10.1002/ijc.34287↗
  2. S100PBP is regulated by mutated KRAS and plays a tumour suppressor role in pancreatic cancer. Co-author DOI 10.1038/s41388-023-02851-y↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tatjana Crnogorac‐Jurcevic · 2 shared papers, 2023 · strength 0.45
  2. Kate E Lines · 1 shared paper, 2023 · strength 0.26
  3. Hui Cai · 1 shared paper, 2023 · strength 0.18
  4. Silvana Debernardi · 1 shared paper, 2023 · strength 0.18
  5. Christie Y. Jeon · 1 shared paper, 2023 · strength 0.18
  6. Xiao‐Ou Shu · 1 shared paper, 2023 · strength 0.18
  7. Qiuyin Cai · 1 shared paper, 2023 · strength 0.18
  8. Oleg B. Blyuss · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.